- Home
- HMST vs CRBU Comparison
HMST vs CRBU Comparison
Compare HMST & CRBU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HMST
- CRBU
- Stock Information
- Founded
- HMST 1921
- CRBU 2011
- Country
- HMST United States
- CRBU United States
- Employees
- HMST N/A
- CRBU N/A
- Industry
- HMST Major Banks
- CRBU Medicinal Chemicals and Botanical Products
- Sector
- HMST Finance
- CRBU Health Care
- Exchange
- HMST Nasdaq
- CRBU Nasdaq
- Market Cap
- HMST 287.6M
- CRBU 236.3M
- IPO Year
- HMST 2012
- CRBU 2021
- Fundamental
- Price
- HMST $11.29
- CRBU $1.98
- Analyst Decision
- HMST Buy
- CRBU Strong Buy
- Analyst Count
- HMST 2
- CRBU 3
- Target Price
- HMST $13.25
- CRBU $14.00
- AVG Volume (30 Days)
- HMST 245.4K
- CRBU 1.9M
- Earning Date
- HMST 10-29-2024
- CRBU 11-06-2024
- Dividend Yield
- HMST 3.46%
- CRBU N/A
- EPS Growth
- HMST N/A
- CRBU N/A
- EPS
- HMST N/A
- CRBU N/A
- Revenue
- HMST $169,710,000.00
- CRBU $11,475,000.00
- Revenue This Year
- HMST N/A
- CRBU N/A
- Revenue Next Year
- HMST $10.09
- CRBU N/A
- P/E Ratio
- HMST N/A
- CRBU N/A
- Revenue Growth
- HMST N/A
- CRBU N/A
- 52 Week Low
- HMST $5.98
- CRBU $1.50
- 52 Week High
- HMST $16.10
- CRBU $8.33
- Technical
- Relative Strength Index (RSI)
- HMST 42.00
- CRBU 43.48
- Support Level
- HMST $10.52
- CRBU $2.37
- Resistance Level
- HMST $11.80
- CRBU $2.08
- Average True Range (ATR)
- HMST 0.60
- CRBU 0.26
- MACD
- HMST 0.18
- CRBU -0.07
- Stochastic Oscillator
- HMST 80.59
- CRBU 6.42
About HMST HomeStreet Inc.
HomeStreet Inc is a commercial bank. It provides commercial loans and consumer loans including mortgage loans, deposit products, private banking, and cash management services. The company loan products include commercial business loans and agriculture loans, consumer loans, single family residential mortgages, loans secured by commercial real estate and construction loans for residential and commercial real estate projects.
About CRBU Caribou Biosciences Inc.
Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies.